Crackdown on cosmetic surgery ‘cowboys' over botched Brazilian butt lifts and Botox
Officials said the industry had been blighted by 'dodgy practitioners and procedures', with some patients 'maimed' during botched treatments.
It follows the case of mother-of-five, Alice Webb, who is thought to be the first person to have died following a non-surgical liquid Brazilian butt lift (BBL) procedure at a UK clinic.
The Department of Health and Social Care (DHSC) has proposed new restrictions on who can access and provide treatments in a bid to protect people from 'rogue operators' with no medical training who often provide 'invasive' procedures in homes, hotels and pop-up clinics.
The move should also reduce the cost imposed upon the NHS to fix botched procedures, DHSC added.
Tim Mitchell, president of the Royal College of Surgeons of England, hailed the proposals as an 'important first step forward for patient safety.'
Health minister Karin Smyth said: 'The cosmetics industry has been plagued by a Wild West of dodgy practitioners and procedures.
'There are countless horror stories of cosmetic cowboys causing serious, catastrophic damage.'
She said the government would take action too 'root out cowboys' and support 'honest and competent practitioners.'
'This isn't about stopping anyone from getting treatments – it's about preventing rogue operators from exploiting people at the expense of their safety and keeping people safe,' Ms Smyth added.
'We're giving them peace of mind and reducing the cost to the NHS of fixing botched procedures.'
The government's proposals include:
Only allowing healthy workers who are 'suitably qualified' to be able to deliver high-risk procedures such as (BBLs)
Ensuring providers are regulated by the health regulator, the Care Quality Commission.
Slapping sanctions and finanial penalties on those who break rules on high-risk procedures
Ensuring clinics offering Botox and fillers are licensed
Introducing age restrictions to prevent children from trying to follow 'dangerous beauty trends on social media'
The timeline for the introduction and completion of these measures was not stated. But the DHSC said it will launch a consultation next year seeking views on the range of procedures which should be covered in the new restrictions.
Last month, the Chartered Trading Standards Institute warned that fat injections, BBLs, Botox and fillers are being offered by untrained people in places such as public toilets.
Before the proposed regulations come into force, the government has urged people seeking cosmetic procedures to ask for the provider's qualifications and insurance, and to be wary of 'suspiciously cheap' offers.
Health officials launched an investigation after a number of people had reactions to Botox injections earlier this year.
Professor David Sines CBE, the chair and registrar of Joint Council for Cosmetic Practitioners (JCCP), said the move will 'protect the public from untrained and inexperienced operators and it will save the NHS a considerable amount of time and money putting right the harm done through botched procedures.'
The statement added the need for the new measures had become increasingly clear in recent years with the 'explosion of high street outlets offering high-risk procedures delivered by people with limited clinical knowledge and training.'
He warned this has led to long-term health complications and, in some cases, has led to patient deaths.
Mr Mitchell suggested the government must go further on liquid Brazilian Butt Lifts, which the RCS said the procedure should only be performed by a Cosmetic Surgery Board-certified surgeon.
The surgeon warned that the procedure needs medical oversight to prevent serious complications and said that while the government's plans will improve the regulation of non-surgical interventions, it must also urgently improve the regulation of surgical procedures.
Millie Kendall, chief executive of the British Beauty Council, said: 'Any measures that increase protection for the general public and professionalise the industry will help instil confidence as well as helping to prevent the normalisation of horror stories that have become synonymous with our sector.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
24 minutes ago
- Telegraph
Majority of British public back prostate screening
Nine in ten Britons want to see prostate cancer screening introduced, polling has found. A survey of 2,000 adults found widespread problems around the current system, which relies on men to come forward and ask GPs for tests when they already have concerns. Polling of the British public found one in five have had a male family member or close friend die from the disease. Among those, more than three quarters believed earlier diagnosis could have saved the life of their loved one. And more than one quarter of those polled had no trust, or not much trust at all, in the current NHS system to detect prostate cancer at an early stage. The poll found 91 per cent of participants thought the NHS should introduce routine screening for prostate cancer screening in men as it does for breast cancer in women. Women aged between 50 and 70 are offered mammograms every five years. More than half of those polled said their opinion of their local MP would worsen if they opposed the introduction of screening. Targeted screening The research by OnePoll was commissioned by charity Prostate Cancer Research, which is calling for the introduction of targeted screening. The survey found a strong desire among its respondents for the NHS to be more proactive about collecting and sharing information about medical history. In total, 69 per cent of those polled said in the event they were diagnosed with prostate cancer, they would want their male family members' NHS records to be automatically updated to reflect this. Having a family history of the disease – like breast and ovarian disease – means an increased risk. There was also considerable appetite for technological innovation, with 60 per cent supporting the use of artificial intelligence (AI) to improve prostate cancer diagnosis, for example, by reading MRI scans faster and more accurately. The call for targeted screening has been backed by MPs including Rishi Sunak, the former prime minister, Sir James Cleverly, the former home secretary, and Calvin Bailey, a Labour MP and the chairman of the all-party parliamentary group on prostate cancer. Wes Streeting, the Health Secretary, has applauded The Telegraph's campaign, saying he would like to see a screening programme in place if the evidence supports it. David James, the director of patient projects and influencing at Prostate Cancer Research, said: 'These poll results send an unequivocal message to policymakers: the public overwhelmingly supports the introduction of a national prostate cancer screening programme. 'The current system is clearly failing to meet the public's expectations for early detection and proactive management of genetic risk. 'With such strong support for investment and participation, it's time for the NHS to prioritise a targeted screening programme that could save countless lives and alleviate the long-term burden on our healthcare system.' Prostate Cancer Research is calling for urgent improvements to screening provision to tackle rising prostate cancer deaths and health inequality in the UK. The charity's research suggests targeted screening – focused on black men, those with BRCA1/2 mutations and those with a family history of the disease – could mean an extra 775 additional early diagnoses per year for those aged between 45 and 69. The research also suggests these changes could spare almost 300 men a year from a stage 4 diagnosis, in which prostate cancer becomes incurable. A Department for Health and Social Care spokesman said: 'Every life lost to prostate cancer is a tragedy. 'We're working to strengthen cancer services across the NHS and will carefully consider the evidence on prostate cancer screening to ensure we're doing everything possible to catch this disease early and save lives. 'This Government has been clear we would like to see screening in place, but the decision must be evidence-led. 'The UK National Screening Committee is looking at this as a priority, including reviewing the evidence for screening men with a family history of prostate cancer and other high-risk groups. 'While this review takes place, we're getting on with improving cancer treatment and prevention – investing £16m in the TRANSFORM trial to find better detection methods, and deploying cutting-edge technology to personalise medicine, catch sickness sooner, and save lives.'
Daily Mail
an hour ago
- Daily Mail
Could YOU have the virus prompting Covid-era restrictions in China? What you need to know about chikungunya virus
China is currently facing what is believed to be the country's largest outbreak of the mosquito-borne chikungunya virus. More than 10,000 cases have been reported in China, and an increasing number of countries across Asia and Europe are reporting near record-high cases or cases for the first time. The CDC has issued a Level 2 travel advisory for China, urging Americans to take extra precautions when visiting the region. However, experts fear the outbreak may have already reached the US. Dr Louisa Messenger, a mosquito researcher in Nevada, told Daily Mail: 'This outbreak in China is very concerning. It [the virus] could already be here in the US; and really it's just one plane flight away.' Chikungunya is primarily spread by Aedes mosquitoes, the same species that carry dengue and Zika viruses. It is rarely fatal but can cause debilitating symptoms, including fever, joint pain and, in severe cases, life-threatening brain and heart damage. Below, Daily Mail reveals everything you need to know about chikungunya virus: What is the situation in China? China has recorded approximately 10,000 chikungunya viruses this year, and about 3,000 of those have cropped up in the last week. Roger Hewson, virus surveillance lead at the UK's Wellcome Sanger Institute, said the current outbreak in China is the largest ever, Al Jazeera reported. To combat the spread of the virus, Chinese officials had ordered travelers from Foshan, the epicenter of the outbreak, to undergo a 14-day home quarantine, similar to Covid restrictions, but that has since been withdrawn. Infected patients are being isolated in hospital wards and covered with mosquito nets. They are required to remain there for a week or until they test negative, if sooner. Images show Chinese state workers spraying clouds of disinfectant around city streets, residential areas and construction sites where people may come into contact with virus-bearing mosquitoes in or near standing water. Drones are also reportedly being used to hunt down insect breeding grounds and spray insecticide, and residents are being asked to empty bottles, flower pots or other outdoor receptacles that may collect water. Failure to comply with any restriction may lead to fines of up to $1,400 (10,000 Yuan) and locals can have their electricity cut off, according to state media. Is the virus in the US? A small number of cases of chikungunya virus are recorded in the US every year. As of August 5, the CDC reported 46 cases of chikungunya in the US this year, all contracted by travelers returning from high-risk areas. No deaths have been reported. It is unclear how many of these could be linked to China's outbreak. Estimates suggest 1.6million people travel between the US and China every year, with experts saying it only takes one bite from a mosquito on one infected traveler to then pass the virus throughout America. The US has experienced limited local transmission of the virus previously. In 2014 and 2015 cases were detected in Florida and Texas. Locally acquired cases in US states and territories have not been reported since 2019, however, according to the CDC. What is the CDC saying? The CDC is warning Americans to take extra precautions when traveling to high-risk areas. In addition to the travel advisory for China, the agency also issued a warning for eight other countries: Bolivia, Kenya, Madagascar, Mauritius, Mayotte, Réunion, Somalia and Sri Lanka. It is advising travelers to wear insect repellent, long-sleeved shirts and pants, and to stay in places with air conditioning. Travelers are also been advised to get vaccinated against chikungunya, with two vaccines available that have been approved in the US. Dr Messenger told this website: 'People should be concerned about these diseases, wear topical repellents, wear long sleeves, and get vaccinated against them if they can.' The CDC says that pregnant women should avoid traveling to high risk areas because they are at higher risk of complications from the virus. What are symptoms? About 15 to 35 percent of people infected with the virus are asymptomatic, the CDC reports. The incubation period is typically three to seven days and the most common symptom is a sudden onset of a fever over 102 degrees Fahrenheit (39 degrees Celsius). Other symptoms of chikungunya virus include headache, nausea, rash, muscle aches, swelling and redness of the conjunctiva (the white part of the eye and inner eyelids) and joint pain that is sometimes severe and debilitating in the hands or feet. In severe cases, life-threatening complications involving the heart and brain can occur such as inflammation, irregular heartbeats and organ failure. Symptoms usually last seven to 10 days, but patients may experience lifelong complications such as persistent joint pain. Those experiencing symptoms or who think they are infected with the virus should contact their primary care provider or visit a hospital. Infections can be diagnosed through a patient history, symptoms, blood tests and serum tests. How is the disease treated? There is no specific treatment for chikungunya virus, though there are several options being investigated, according to the CDC. Doctors instead focus on trying to ease symptoms through rest, fluids and over-the-counter pain relief medications like acetaminophen (Tylenol). For people who continue to experience pain, over-the-counter pain relievers, steroids and physical therapy are typically the course of treatment. There are two vaccines available for chikungunya virus and they are recommended for people visiting areas with an outbreak or that may pose a higher risk of infection.
Telegraph
an hour ago
- Telegraph
Benefits claims among over-50s hit record high
'Older workers bring decades of skills, insight, and experience. Their absence represents a serious depletion of the UK's human capital at a time when economic growth is urgently needed,' it said. 'Even a modest rise in employment among economically inactive people over 50 to 64 years old could generate billions in tax revenue and welfare savings.' The think tank urged the Government to overhaul the sick note system to ensure it better supported older workers with manageable health conditions to remain in work. It also called for new age-specific employment targets for workers in their 50s and 60s. Older workers hit hardest by pandemic The research found the pandemic has had a disproportionate impact on older workers, with the economic inactivity rate among 50 to 64-year-olds at 25.9 per cent as of May this year – more than double the 11.5 per cent rate for 35 to 49-year-olds. The think tank highlighted how people aged 50 to 64 years old accounted for almost a third (32 per cent) of the total increase in economic inactivity among 16 to 64-year-olds since Covid. This translated to around 185,000 more 50 to 64-year-olds who are not in work and not looking for work. By contrast, economic inactivity among those aged 35 to 49 decreased over the same period. The report also highlighted significant gender disparities. Some 29.5 per cent of women were economically inactive in May 2025, compared to 22.2 per cent of men. One of the main reasons for this is barriers to re-entry into the workforce – including caring responsibilities – which disproportionately affected older women. 'Overlooked pool of potential workers' The number of economically inactive older people who said they would like to work declined from 19 per cent in 2015 to 14 per cent last year. Of those willing to work, most are not actively seeking employment. The CSJ said this highlighted a critical yet overlooked pool of potential workers. It urged the Government to establish a new National Work and Health Service to take pressure off GPs and provide better support with workplace adjustments. The report said this change could help to reduce unnecessary workforce drop-out for older workers and keep them meaningfully engaged with employment, even if at a reduced level. The Labour MP Carolyn Harris, a deputy chair of the CSJ, said the research showed the economy was suffering a 'mid-life crisis'. She urged the Government to accelerate its WorkWell scheme, a new integrated work and health support service, to 'stem the flow of the 300,000 or so who exit work every year due to sickness, and ensuring people get the support they need'.
